Somatostatin analogues for thyroid associated ophthalmopathy

Reason for withdrawal from publication Author team unable to complete the updated protocol. This protocol (originally published by the Cochrane Metabolic and Endocrine Disorders Group) has now been taken over by the Cochrane Eyes and Vision Group. As reviews are already underway on corticosteroids and orbital radiotherapy, this review will now focus on somatostatin analogous. The review team are currently updating this protocol to reflect this change. To view the published versions of this article, please click the 'Other versions' tab.